Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Megan A Waldrop

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|September 6, 2024
Clinical decision making around commercial use of gene and genetic therapies for spinal muscular atrophyMegan A Waldrop
Neurologic Clinics|July 25, 2020
Spinal Muscular Atrophy in the Treatment EraMegan A Waldrop, Bakri H Elsheikh
Pediatric Pulmonology|September 5, 2020
Overview of gene therapy in spinal muscular atrophy and Duchenne muscular dystrophyNicolas J Abreu, Megan A Waldrop
Current Treatment Options in Neurology|May 1, 2019
Current Treatment Options in Neurology-SMA TherapeuticsMegan A Waldrop, Stephen J Kolb
Current Opinion in Neurology|July 26, 2019
Update in Duchenne and Becker muscular dystrophyMegan A Waldrop, Kevin M Flanigan
Seminars in Pediatric Neurology|April 24, 2021
Spinal Muscular AtrophyStefan Nicolau, Megan A Waldrop, Anne M Connolly, et al.
Muscle & Nerve|May 7, 2021
Time is muscle: A recommendation for early treatment for preterm infants with spinal muscular atrophyBo Hoon Lee, Megan A Waldrop, Anne M Connolly, et al.
Annals of Neurology|February 15, 2020
The Genotypic and Phenotypic Spectrum of BICD2 Variants in Spinal Muscular AtrophyDaniel C Koboldt, Megan A Waldrop, Richard K Wilson, et al.
Endocrinology|June 23, 2007
Release of glutamate decarboxylase-65 into the circulation by injured pancreatic islet beta-cellsMegan A Waldrop, Arthur T Suckow, Santica M Marcovina, et al.
Pediatric Neurology|July 6, 2017
Clinicopathologic Conference: A Newborn With Hypotonia, Cleft Palate, Micrognathia, and Bilateral Club FeetMegan A Waldrop, Daniel R Boue, Emily Sites, et al.
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|September 6, 2024
Clinical decision making around commercial use of gene and genetic therapies for spinal muscular atrophyMegan A Waldrop
Neurologic Clinics|July 25, 2020
Spinal Muscular Atrophy in the Treatment EraMegan A Waldrop, Bakri H Elsheikh
Pediatric Pulmonology|September 5, 2020
Overview of gene therapy in spinal muscular atrophy and Duchenne muscular dystrophyNicolas J Abreu, Megan A Waldrop
Current Treatment Options in Neurology|May 1, 2019
Current Treatment Options in Neurology-SMA TherapeuticsMegan A Waldrop, Stephen J Kolb
Current Opinion in Neurology|July 26, 2019
Update in Duchenne and Becker muscular dystrophyMegan A Waldrop, Kevin M Flanigan
Seminars in Pediatric Neurology|April 24, 2021
Spinal Muscular AtrophyStefan Nicolau, Megan A Waldrop, Anne M Connolly, et al.
Muscle & Nerve|May 7, 2021
Time is muscle: A recommendation for early treatment for preterm infants with spinal muscular atrophyBo Hoon Lee, Megan A Waldrop, Anne M Connolly, et al.
Annals of Neurology|February 15, 2020
The Genotypic and Phenotypic Spectrum of BICD2 Variants in Spinal Muscular AtrophyDaniel C Koboldt, Megan A Waldrop, Richard K Wilson, et al.
Endocrinology|June 23, 2007
Release of glutamate decarboxylase-65 into the circulation by injured pancreatic islet beta-cellsMegan A Waldrop, Arthur T Suckow, Santica M Marcovina, et al.
Pediatric Neurology|July 6, 2017
Clinicopathologic Conference: A Newborn With Hypotonia, Cleft Palate, Micrognathia, and Bilateral Club FeetMegan A Waldrop, Daniel R Boue, Emily Sites, et al.
Pageof 5